BT-001, an oncolytic Vaccinia virus armed with a Treg-depletion-optimized recombinant human anti- CTLA4 antibody and GM-CSF to target the tumor microenvironment
Poster BT-001 Marchand, Semmrich, Fend et al. Immuno-Oncology summit Download the posterhere Poster Presentation